Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri NCIMB 30242 and Reduced Blood Cholesterol

Research synthesisModerate evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

All 3 studies reported beneficial effects on reduced blood cholesterol, with predominantly small effect sizes. The strongest evidence comes from a randomized controlled trial in hypercholesterolemic adults (n=127) showing a 9.14% reduction in total cholesterol (p<0.001). Dosage and study duration were not consistently reported across studies.

  • Studied populations: hypercholesterolemic adults

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Study durations were not consistently reported.

Generated Jul 24, 2026
4 of 4 papers
Back to top